Applied Therapeutics, Inc. — Director's Dealing 2019

May 29, 2019

SEC Form 3/A — Form 3/A

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-13

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Perferred Stock	$		Common Stock (88397)		Indirect

Footnotes

F1: Each share of Series A Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a one-for-one basis, has no expiration date and is expected to automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.

F2: These securities were unintentionally omitted from the Reporting Person's initial Form 3.

F3: The reportable securities are directly owned by Clearpoint Strategy Group LLC ("Clearpoint") of which the Reporting Person is the sole owner. The Reporting Person has sole voting and dispositive power over these securities.